These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2889461)

  • 1. The effect of famotidine on renal function in patients with renal insufficiency.
    Abraham PA; Opsahl JA; Halstenson CE; Chremos AN; Matzke GR; Keane WF
    Br J Clin Pharmacol; 1987 Sep; 24(3):385-9. PubMed ID: 2889461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of famotidine, a new histamine H2-receptor antagonist, on renal function.
    Ishigami M; Sezai Y; Shimada Y; Maeda T; Yabuki S
    Nihon Jinzo Gakkai Shi; 1989 Jun; 31(6):687-91. PubMed ID: 2571741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of H2 receptor blockers on renal function. An attempt to accurately measure glomerular filtration].
    Motyl W
    Ann Acad Med Stetin; 2004; 50(1):97-105. PubMed ID: 16871748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of age and chronic renal failure on the urinary excretion kinetics of famotidine in man.
    Lin JH; Chremos AN; Yeh KC; Antonello J; Hessey GA
    Eur J Clin Pharmacol; 1988; 34(1):41-6. PubMed ID: 2896129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of famotidine in elderly patients with and without renal insufficiency and in healthy young volunteers.
    Inotsume N; Nishimura M; Fujiyama S; Sagara K; Sato T; Imai Y; Matsui H; Nakano M
    Eur J Clin Pharmacol; 1989; 36(5):517-20. PubMed ID: 2568929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of famotidine, a new H2-receptor antagonist, in relation to renal function.
    Takabatake T; Ohta H; Maekawa M; Yamamoto Y; Ishida Y; Hara H; Nakamura S; Ushiogi Y; Kawabata M; Hashimoto N
    Eur J Clin Pharmacol; 1985; 28(3):327-31. PubMed ID: 2861096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cimetidine administration and tubular creatinine secretion in patients with compensated cirrhosis.
    Sansoè G; Ferrari A; Castellana CN; Bonardi L; Villa E; Manenti F
    Clin Sci (Lond); 2002 Jan; 102(1):91-8. PubMed ID: 11749665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Famotidine, a new H2-receptor antagonist, does not affect hepatic elimination of diazepam or tubular secretion of procainamide.
    Klotz U; Arvela P; Rosenkranz B
    Eur J Clin Pharmacol; 1985; 28(6):671-5. PubMed ID: 2866097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.
    Lin JH
    Clin Pharmacokinet; 1991 Mar; 20(3):218-36. PubMed ID: 1673880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics of famotidine in humans.
    Chremos AN
    Am J Med; 1986 Oct; 81(4B):3-7. PubMed ID: 2877572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of H2-receptor antagonists on renal function in cyclosporine-treated renal transplant patients.
    Pachon J; Lorber MI; Bia MJ
    Transplantation; 1989 Feb; 47(2):254-9. PubMed ID: 2645708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of H2 antagonists on the differential secretion of triamterene and its sulfate conjugate metabolite by the isolated perfused rat kidney.
    Muirhead MR; Somogyi AA
    Drug Metab Dispos; 1991; 19(2):312-6. PubMed ID: 1676629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effect of famotidine and cimetidine on the pharmacokinetics of theophylline in normal volunteers.
    Lin JH; Chremos AN; Chiou R; Yeh KC; Williams R
    Br J Clin Pharmacol; 1987 Nov; 24(5):669-72. PubMed ID: 2893637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creatinine clearance following cimetidine for estimation of glomerular filtration rate.
    Hellerstein S; Berenbom M; Alon US; Warady BA
    Pediatr Nephrol; 1998 Jan; 12(1):49-54. PubMed ID: 9502568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate.
    van Acker BA; Koomen GC; Koopman MG; de Waart DR; Arisz L
    Lancet; 1992 Nov; 340(8831):1326-9. PubMed ID: 1360044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of famotidine.
    Echizen H; Ishizaki T
    Clin Pharmacokinet; 1991 Sep; 21(3):178-94. PubMed ID: 1764869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the monkey an appropriate animal model to examine drug-drug interactions involving renal clearance? Effect of probenecid on the renal elimination of H2 receptor antagonists.
    Tahara H; Kusuhara H; Chida M; Fuse E; Sugiyama Y
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1187-94. PubMed ID: 16291876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does H2-receptor antagonist alter the renal function of cyclosporine-treated kidney grafts?
    Inoue S; Sugimoto H; Nagao T; Akiyama N
    Jpn J Surg; 1990 Sep; 20(5):553-8. PubMed ID: 2243448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic studies on the competition between famotidine and cimetidine in rats. Evidence of multiple renal secretory systems for organic cations.
    Lin JH; Los LE; Ulm EH; Duggan DE
    Drug Metab Dispos; 1988; 16(1):52-6. PubMed ID: 2894955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranitidine has no influence on tubular creatinine secretion.
    van den Berg JG; Koopman MG; Arisz L
    Nephron; 1996; 74(4):705-8. PubMed ID: 8956305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.